Cystic Fibrosis Foundation

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Astra Microwave Products’ ₹2,205.23 crore order for 122 Active Antenna Array Units and 121 interface frames underscores the scale of India’s Uttam Radar programme and the long-cycle manufacturing opportunity tied to its five-year delivery schedule. Representative image.

HAL’s Rs 2,205cr Uttam Radar order transforms Astra Microwave’s visibility

CN Energy Group has entered direct North American crude production through an Alberta Cold Lake oil well investment, expanding beyond its traditional businesses as it builds a broader platform spanning oil production, transportation, trading and supply-chain services. Representative image.

CN Energy (NASDAQ: CNEY) enters Canadian oil production with Cold Lake project

NLC India is seeking 1,500 acres of private land for utility-scale solar projects in Tamil Nadu, implying around 300 MW of initial capacity with potential expansion to roughly 600 MW under a green-shoe option. Representative image.

PowerBank (NASDAQ: PBK) clears permit for C$14m Nova Scotia solar project

Continental Resources is expanding its Permian Basin footprint through the acquisition of FireBird Energy II, adding about 54,000 net Midland Basin acres and 32,000 barrels of oil equivalent per day of production, including a 69% oil mix. Representative image.

Continental Resources to buy FireBird as Permian footprint grows more than 40%

Representative image: Eli Lilly and Company’s acquisition of Engage Biologics highlights big pharma’s growing interest in non-viral DNA delivery platforms for next-generation genetic medicines.

Lilly (LLY) acquires Engage Biologics for up to $202m to advance non-viral DNA delivery platform

Eli Lilly (NYSE: LLY) acquires Engage Biologics for up to $202 million, adding the Tethosome non-viral DNA platform to its genetic medicines portfolio. Read more.

byVenkatesh

May 20, 2026

Synspira’s PAAG15A receives orphan drug designation for cystic fibrosis treatment

Synspira Therapeutics’ investigational inhaled treatment, PAAG15A, has been granted orphan drug designation by the U.S. Food and Drug…

bypharmanewsdaily

October 14, 2018

The Latest

HAL’s Rs 2,205cr Uttam Radar order transforms Astra Microwave’s visibility

CN Energy (NASDAQ: CNEY) enters Canadian oil production with Cold Lake project

PowerBank (NASDAQ: PBK) clears permit for C$14m Nova Scotia solar project

Continental Resources to buy FireBird as Permian footprint grows more than 40%

Lilly (LLY) acquires Engage Biologics for up to $202m to advance non-viral DNA delivery platform

Synspira’s PAAG15A receives orphan drug designation for cystic fibrosis treatment

HAL’s Rs 2,205cr Uttam Radar order transforms Astra Microwave’s visibility

CN Energy (NASDAQ: CNEY) enters Canadian oil production with Cold Lake project

PowerBank (NASDAQ: PBK) clears permit for C$14m Nova Scotia solar project

Continental Resources to buy FireBird as Permian footprint grows more than 40%

Mitsubishi Electric’s $1.4bn PCI deal targets software managing 60% of US power

Equinor strikes three-year ORLEN deal for up to 9m tonnes of crude a year

APA Group (ASX: APA) commits A$259m to Mount Isa solar and battery project

MV Ocean Winner sinks off Odisha as 22 crew remain missing in Bay of Bengal